BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 205324)

  • 1. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra.
    Innis RB; Aghajanian GK
    Brain Res; 1987 May; 411(1):139-43. PubMed ID: 2955848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitro.
    Brase DA
    J Pharm Pharmacol; 1980 Jun; 32(6):432-3. PubMed ID: 6106680
    [No Abstract]   [Full Text] [Related]  

  • 6. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF; Arbuthnott GW; Wright AK; Garcia-Munoz M; Nicolaou NM
    Psychol Med; 1978 Aug; 8(3):471-82. PubMed ID: 30106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of nigral dopamine receptors?
    Glick SD; Crane LA
    Brain Res; 1978 Nov; 156(2):380-1. PubMed ID: 568507
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function.
    Kelly PH; Moore KE
    Nature; 1976 Oct; 263(5579):695-6. PubMed ID: 980114
    [No Abstract]   [Full Text] [Related]  

  • 9. On the cyclic nucleotides involvement in rat striatal function.
    Carenzi A; Govoni S; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1976 Oct; 8(5):519-24. PubMed ID: 194261
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry.
    Gonon FG
    Ann N Y Acad Sci; 1986; 473():160-9. PubMed ID: 3492168
    [No Abstract]   [Full Text] [Related]  

  • 11. Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia.
    Waszczak BL; Lee EK; Ferraro T; Hare TA; Walters JR
    Brain Res; 1984 Jul; 306(1-2):307-18. PubMed ID: 6466980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.
    Baring MD; Walters JR; Eng N
    Brain Res; 1980 Jan; 181(1):214-8. PubMed ID: 7350957
    [No Abstract]   [Full Text] [Related]  

  • 14. Responsiveness of nigral neurons to the stimulation of striatal dopaminergic receptors in the rat.
    Scarnati E; Forchetti C; Ciancarelli G; Pacitti C; Agnoli A
    Life Sci; 1980 Apr; 26(15):1203-9. PubMed ID: 7392796
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 16. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons?
    Roth RH; Doherty JD; Walters JR
    Brain Res; 1980 May; 189(2):556-60. PubMed ID: 7370791
    [No Abstract]   [Full Text] [Related]  

  • 17. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S
    Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.